Human tissue experiments are imperative for health research. Solid tissue is an invaluable substrate to understand the molecular and cellular mechanisms underlying childhood diseases. Tissue samples can be collected from subjects across the developmental spectrum, from fetal to late adolescent stages. Children with diseases can also live into adulthood, which may necessitate collection of tissue in later life. In the present review, which is the fourth in a series on tissue sampling and biobanking for child-health studies, [1] [2] [3] we describe issues that arise from the collection, processing, and storage of solid tissues. Our goals were to highlight the ethical standards for solid tissue collection from children and the various factors affecting tissue integrity. In addition, we reviewed newer methods for determining tissue quality.
ETHICS STANDARDS FOR SOLID TISSUE RESEARCH
Tissue retrieval for research purposes can be complicated by concerns for the individual's legitimate ethical rights, religious beliefs, and emotional well-being. Biobanks typically have a well-organized informed consent system, whereas the consent standards for archival tissues can be variable. Published ethical guidelines for biobanks suggest the following: (1) that children, as soon as mentally capable, should be asked to assent to research; (2) that biobanks collecting non-postmortem tissue should abstract Solid tissues are critical for child-health research. Specimens are commonly obtained at the time of biopsy/surgery or postmortem. Research tissues can also be obtained at the time of organ retrieval for donation or from tissue that would otherwise have been discarded. Navigating the ethics of solid tissue collection from children is challenging, and optimal handling practices are imperative to maximize tissue quality. Fresh biopsy/surgical specimens can be affected by a variety of factors, including age, gender, BMI, relative humidity, freeze/thaw steps, and tissue fixation solutions. Postmortem tissues are also vulnerable to agonal factors, body storage temperature, and postmortem intervals. Nonoptimal tissue handling practices result in nucleotide degradation, decreased protein stability, artificial posttranslational protein modifications, and altered lipid concentrations. Tissue pH and tryptophan levels are 2 methods to judge the quality of solid tissue collected for research purposes; however, the RNA integrity number, together with analyses of housekeeping genes, is the new standard. A comprehensive clinical data set accompanying all tissue samples is imperative. In this review, we examined: the ethical standards relating to solid tissue procurement from children; potential sources of solid tissues; optimal practices for solid tissue processing, handling, and storage; and reliable markers of solid tissue quality.
make an effort to recontact young adults for re-consent once they are capable of providing it; and (3) that minors, when permitted by law, withdraw their samples and clinical data regardless of their parents' consent. [4] [5] [6] Broad consent to cover unexpected studies is ideal, but if the research changes significantly from the original protocol, ethics committees should decide whether re-consent is necessary. 4 Archived tissues should be anonymized and consented for by the patients and/ or their legal guardian. Internal resource committees should approve access to specimens. 7 Acquiring parental/guardian consent for tissues is often difficult due to fear and/or grieving, but many still consent because they believe that tissue research may be useful for the development of new drugs and treatments 8 and/or because of a wish to prevent others from similar painful situations. 9 Obtaining consent from relatives after a child dies requires biobank staff to have sensitivity and training to avoid coercion and exacerbating distress. Tissue procurement via percutaneous needle biopsy, as opposed to full open autopsy, may be of greater acceptability to parents/ guardians, but this approach can introduce sampling errors. 10 In addition, obtaining consent for tissues to be used in research must be coordinated with organ procurement organizations.
Although predeath autopsy permission for research tissues may be obtained during the informed consent process, 11,12 the institutional review board in accordance with law requires postmortem confirmation of the permission from the research participant's legally authorized representative. [13] [14] [15] Additional issues to be considered by biobanks include the following: recruiting properly qualified professionals with religious and cultural knowledge to participate on research ethics committees (ie, pediatricians, lawyers, community members); access to larger numbers of shared control cases; standardized protocols between laboratories; and procedures for handling genetic information, incidental findings in DNA studies, and ownership rights.
Recent advances in human tissue engineering and organoids require unique guidelines and procedures. 16 The moral status of interfering with the beginning of life when using human embryonic stem and fetal cells is always questioned. Acquired tissues should only be used for the informed research purpose, and parents often consent only to autologous use with respect to a child's tissues. Researchers are encouraged to educate the public about their work, although it is challenging to provide details about the tissue engineering process to a lay audience.
Internationally, human tissue research is controlled by federal regulations, and studies require approval by research ethics committees or institutions' review boards. 12-14,17-23 Different approaches for informed consent and/or assent should be implemented in child research according to the targeted age (from fetal to adolescent stages). 6 Several guidelines are available for access, use, legal rights, handling genetic information, and the sharing of biological samples for research purposes. [24] [25] [26] [27] [28] In addition, the Genetic Privacy Act and Commentary, 29,30 the Genetic Information Nondiscrimination Act, 31 and the Health Insurance Portability and Accountability Act (termed the Privacy Rule) 32 were created to regulate genetic information and individual identifiable health information release. Commercial biobanks have raised significant ethical and legal issues, prompting several countries to create comprehensive regulations through mechanisms such as licensure. 33 
SOURCES AND TYPES OF SOLID TISSUES COLLECTED
Sources of solid tissue for childhealth research include local collections, biobanks, and archived tissues collected as normal clinical practice by pathology laboratories. With the development of newer technologies to identify and quantify molecular biomarkers, including DNA microarrays, quantitative polymerase chain reaction (PCR), and mass spectrometry, biobanking is critical for many disease investigations, whereas archived tissue has been mainly used to detect rare diseases or to investigate specific populations. 34 A variety of solid tissues have been collected for health research (Table  1) . Biopsy/surgical specimens are collected to test histopathologic features [35] [36] [37] [38] ; to determine pathogenic mediators 36, [39] [40] [41] ; to obtain a definitive diagnosis of different syndromes, disorders, or diseases 37, 42, 43 ; to test the safety of different techniques 44, 45 ; to study the role of toxic elements 46 ; and to diagnosis new or rare diseases. 47 Biopsy/surgical specimens reflect the tissue in vivo state, but collection is hampered by accessibility, limited volume, or because the sampled area may not fully represent the disease. 10, 48 Pediatric tissue is also required in studies on the normal development of the human. [49] [50] [51] Fresh tissues can be used for engineering and regenerative medicine. 165 Donor somatic cells (fibroblasts from skin, adipose cells, and bone marrow; blood mononuclear cells from peripheral blood), term placenta cells, fetal and neonatal cells, and umbilical cord cells are all excellent sources of embryonic and adult stem cells. These cells can potentially be used in tissue replacement therapies, human in vitro models of disease, screening of therapeutic and toxic effects of chemicals, and personalized medicine. 166 Lack of accessibility of fresh tissue makes postmortem tissue an important alternative. Postmortem tissue has been used for studies on morphology [167] [168] [169] [170] [171] ; to study the mechanical properties of different organs 167, 168 ; to validate new techniques [172] [173] [174] ; to correlate morphology with microbiology findings 103 ; to report new or rare diseases 175 ; to study the molecular mechanisms 95,123 to determine toxic element exposure 87 ; to determine a definitive disease diagnosis 88, 96, 104, 176 ; and to detect infectious agents. 10, 68 The use of postmortem tissue is often hampered, however, by agonal factors, postmortem intervals (PMIs), and storage conditions that contribute to tissue degradation. 177, 178 Solid tissues can be derived from living patient organ donors, as well as from deceased patients, resulting from neurologic or cardiac death. [179] [180] [181] [182] [183] Recovery of donor medical information before the donor tissue procurement is ideal, 184 particularly in preregistered cases, and it can be supplemented with archived medical records. Importantly, the case must meet the collection criteria of the tissue bank. Exclusion criteria will vary according to project and may include drug usage, cancer, psychiatric illnesses, and extended PMI. Obtaining consent for tissue procurement is often the initial focus (if not acquired in advance), followed by tissue retrieval.
Tissue quality, physiology, and function are critical for tissue donation, as is the patient's medical condition at the time of death and the patient's location (termed geographical limitation). 179 The viability of the tissues is measured in hours from the moment of retrieval, which is a time critical for successful transplantation or research. 20 For example, ocular tissue must be recovered within 12 hours of cardiocirculatory death for transplantation, but it can be used for research within 15 to 24 hours of cardiocirculatory death. 179 Tissue banks often interact permanently with universities, hospitals, medical centers, and support foundations, and they offer a variety of organs/tissues for child-health research. [180] [181] [182] [183] Tissue that would otherwise have been discarded, including placentas and umbilical cords, can be obtained for research purposes because their collection poses little risk to the patients. [185] [186] [187] The placenta has been used in child-health research to investigate preeclampsia, 188 maternal obesity, 63 endocrine disruptors, 189 attention-deficit/hyperactivity disorder, 64 Smith-Lemli-Opitz syndrome, 190 and vertical virus transmissions. 65, 66 Blood drawn from umbilical cord veins has been used for regenerative medicine 72 and stem cell research. 191, 192 Other discarded tissues include the aborted fetus, 193, 194 
FRESH, FRESH FROZEN, AND FIXED TISSUES
Fresh, fresh frozen, and fixed tissues are amenable to several investigative methods, including tissue engineering, microarray analysis, PCR, receptor autoradiography, proteomics, chromatography, immunochemistry, and protein sequencing (Table 3) . [207] [208] [209] Fresh tissue is used for tissue engineering research and organoid formation, following digestion of extracellular matrix and cell isolation in a sterile environment. 166 When isolated cells are reprogrammed to stem cells and the end point is differentiation to specific cell lineages, specific media conditions must be used. Because tissue function often relies on several cell types in a specific 3-dimensional order, the development of novel culture environments using biomaterials and bioreactors is imperative to maintain selected aspects of native tissue. 166 Mechanical stimuli, extracellular matrix components, or even long-term cell culture conditions are extremely important for the development of an organoid. 166 Fresh frozen tissue preserves biomolecules in an intact state and provides a high yield of quality DNA and RNA. 225, 226 Due to the small sample size of fresh frozen tissue, however, it is often difficult to correlate biochemical experiments with histologic/pathologic examinations. 225 Regardless of the tissue origin (either biopsy/surgical or postmortem), snap-freezing with storage at -80°C or below are ideal to maintain the integrity of biochemical molecules. 207, 210, 227 Tissue samples are often fixed in formaldehyde or formalin before being embedded in paraffin wax for sectioning and subsequent histologic examination. Fixed tissue is most commonly used for protein localization and morphology studies. Paraffin blocks have been successfully used to isolate both DNA and RNA when optimal fixation and extraction methods were used. 228 However, fixation of solid tissue can degrade and damage DNA and RNA, 225, 229 thus interfering with gene expression, mutation, and polymorphism studies. For better quality tissue, fixation should be conducted as soon as possible after collection, 209 and the samples should be immediately embedded in paraffin blocks. 229 DNA can be isolated from fixed tissue that has not yet been embedded, 225 but the DNA is of less quality compared with DNA isolated from frozen tissue.
FACTORS INFLUENCING SOLID TISSUE QUALITY
Many factors affect the quality of tissue directly or indirectly by interfering with protein stability and nucleotide yield or quality. 67, 177, [230] [231] [232] [233] [234] The parameters affecting solid tissue qualities are summarized in Table 4 .
Gender and Age
Female gender and increased age at death are 2 factors that influence total tissue messenger RNA levels 256 and alter specific gene expression profiles. 258 Although both factors are reportedly important determinants of tissue quality, 232, 258 other research has shown that brain RNA integrity is not influenced by gender or age <50 years (H.R.Z., unpublished observations). 236 Agonal factors, such as coma and hypoxia, can markedly affect the RNA quality and have a major impact on gene expression profiles in microarray analyses. 232 The activation of ribonucleases during the terminal phase may introduce large divergences of global gene expression profiles in microarrays compared with gender, age, postmortem delays, or diagnoses of psychiatric disorders. 232 A sudden or prolonged death can affect tissue quality, resulting in the creation of the agonal factor score (AFS). 232 Each agonal condition is scored 1 if present or 0 if absent. Agonal duration is also rated. 261 Individual scores of the agonal conditions and agonal duration are summed to provide the final AFS for each sample. A lower AFS is associated with high-quality tissue. 233 The AFS has the practical limitation of its inability to assess each anatomic region separately, resulting in the development of an agonal stress rating system that evaluates the degree of stress based on gene expression data. 237 The agonal stress rating can reduce the number of false-positive findings by allowing a quantitative 113 • PPT1, caspase-3, cleaved-PARP, caspase-9, ROS, and SOD-2 113 • Infi ltrative glioma and gliosis 53 • EGFR 53 • Autism [197] [198] [199] • Neuronal microexons, 197 • Infantile X-linked dilated cardiomyopathy 200 • Saturated fatty acids, mitochondria structure 200 • Dilated cardiomyopathy and congenital heart disease 137
Agonal Factors
• Levels of HHV-6 137
• Chagas disease 35 • Quilty effect, rejection, C myocarditis reactivation, fi brosis, hypertrophy, and ischemia; as well as lymphocytic cellular infi ltration of myocarditis 35 • Cardiovascular development 167, 168 • Morphology and mechanical properties of the atrial intima 167 • Acquired immune defi ciency syndrome 204 • CD4+ T-cell 2 count and HIV viral load, fecal calprotectin, and bowel ultrasound, with the latter evaluating bowel wall thickness and mesenteric lymph nodes 204 Bone marrow PCR, PCR-RFLP, histologic evaluation (Giemsa staining), bone marrow culture 205 • Visceral leishmaniasis 205 • Leishmania DNA 205 Skin Histologic evaluation (H&E), immunoperoxidase 206 • Primary cutaneous plasmacytosis 206 • Search for cell infi ltration of dermis, clusters of B-lymphocytes CD20 reactive, and expression of κ light chains and λ light chains to diagnosis rare disease 206 • Exposure to endocrine disruptors during pregnancy and infancy 189 • Levels of non-POPs (including MEHP, OP, and 4-NP), and PBDEs 189 
Postmortem Intervals
A PMI is defined as the difference between the time of death and the time of tissue preservation (eg, frozen, fixed). 184 After death, bodies are placed at 4°C for variable times before sample collection. Traditionally, PMIs can range from 6 to 72 hours, 262 depending on the period of time that parents wish to remain with their deceased child, with 1 to 6 hours as the minimum time to access the body for tissue collection. 184 High-quality tissue is generally associated with low PMIs. 233, 263, 264 Longer PMIs alter the tissue quality at the molecular level. Postmortem tissue can maintain gene expression profiles in heart tissue for at least 24 hours, 78 whereas longer PMIs result in greater epithelial cell loss in cornea tissue. 245 Delays in PMI can also affect protein stability, particularly receptors and cytosolic proteins. 251, 253, 265 PMI delays >40 hours result in posttranslational modifications and decrease protein immunoreactivity in human degenerative diseases. 241, 254, 266, 267 Longer PMIs are associated with oxidation/nitration events. 240 
Other Factors Affecting Solid Tissue Quality
After death, the time to tissue collection, extraction, and processing, as well as tissue storage protocols and temperatures, are critical factors affecting tissue quality (Table 5 ). For example, brain RNA and protein degradation associated with postmortem delay is dependent on the storage temperature. 210, 234, 268 ADORA2B, adenosine A2B receptor; CAPN2, calpain-2 catalytic subunit 2; CAR, androstane receptor; CCL, chemokine (C-C motif) ligand; CD3, cluster of differentiation 3; CD4, cluster of differentiation 4; CD20, cluster of differentiation 20; CD68, cluster of differentiation 68; CoQ10, coenzyme Q10; CpG, C-phosphate-G (cytosine nucleotide sites); 13 C-UBT, 13 C-urea breath test; c-Src, Proto-oncogene tyrosine-protein kinase Src; CTCF, CCCTC-binding factor; CXCL1, the chemokine (C-X-C motif) ligand 1; DCX, doublecortin; EGFR, epidermal growth factor receptor; EPHX2, epoxide hydrolase 2; FACS, fl uorescence-activated cell sorting; FAK, focal adhesion kinase; FISH, fl uorescence in situ hybridization; fqPCR, fl uorescent quantitative PCR; Gli-RFP reporter, Gli luciferase reporter; GM-CSF, granulocyte-macrophage colony-stimulating factor; GR, glucocorticoid receptor; ICC, immunocytochemistry; IF, immunofl uorescence; IHC, immunohistochemistry; IL, interleukin; iNOS, inducible nitric oxide synthase; HA117, a novel multidrug resistance gene; H&E, hematoxylin and eosin; Hh, Hedgehog; HHV-6, human herpesvirus 6; HIV-1, HIV type 1; HNF1α, hepatocyte nuclear factor 1α; HNF4α, hepatocyte nuclear factor 4α; HPLC, high-performance liquid chromatography; iPSCs, induced pluripotent stem cells; Ki67, antigen identifi ed by monoclonal antibody; MDR1, multidrug resistance 1; MeDIP, methylated DNA immunoprecipitation; MEHP, mono-2-ethylhexylphthalate; MLCK, myosin light-chain kinase; MRP2, multidrug resistance protein 2; NANOG, homeobox protein NANOG; non-POPs, non-persistent organic pollutants; 4-NP, 4-nonylphenol; OATP1B1, organic anion transporting polypeptide 1B1; OATP1B3, organic anion transporting polypeptide 1B3; OATP2B1, organic anion transporting polypeptide 2B1; OCT4, octamer-binding transcription factor 4; OP, octylphenol; p130Cas, Crk-associated substrate; PARP, poly (ADP-ribose) polymerase; PBDEs, polybrominated diphenyl ethers; PCNB, percutaneous core needle biopsy; P-gp, permeability glycoprotein; P-MLC20, phosphorylated myosin regulatory light chain; PPT1, palmitoyl protein thioesterase-1; PXR, pregnane X receptor; Q-FISH, quantitative fl uorescence in situ hybridization; ROS, reactive oxygen species; SDF2, stromal cell-derived factor 2; SOD-2, superoxide dismutase-2; SOX2, sex determining region Y-box 2; SOX7, SRY-related HMG-box 7; SSEA4, stage-specifi c embryonic antigen-4; SUPER, sub-urothelial polyp enucleation resection; RT-PCR, reverse transcription PCR; RUT, rapid urease test; Tbdn, Tubedown; TCF7L2, transcription factor 7-like 2; TNF, tumor necrosis factor; UAAC, urothelial auto-augmentation cystoplasty; UGT1A1, UDP-glucuronosyltransferase 1A1; VLC, very long chain fatty acids. a Defi ned as regraft or, in the absence of regraft, a cloudy cornea in which there was loss of central graft clarity suffi cient to compromise vision for a minimum of 3 consecutive months. b CD4 + T cells refer to cells that express the surface protein CD4. c For kidney tissue only. 
INDICATORS OF TISSUE QUALITY

RNA Integrity
RNA integrity is an important indicator of tissue quality. The most common and sensitive method used for determination of total RNA quality, with high reproducibility and with impartial measurements, is microfluidic chip-based capillary electrophoresis 270,271 using a Bioanalyzer (Agilent Technologies, Santa Clara, CA) or Experion (BioRad Laboratories, Munich, Germany) instrument. Using electrophoretic data, an RNA integrity number (RIN) or RNA quality index is generated, taking into account the 18S/28S ribosomal RNA peaks, as well as background and degradation products. The RIN can range from undetectable to 10, with undetectable being completely degraded and 10 being mostly intact RNA 233 ; RIN values ≤6 are usually considered insufficient for RNA studies. 210 RNA integrity can be influenced by degradation, tissue type, BMI, and by other tissue quality markers, including pH, PMI, agonal factors, and relative humidity of the processing laboratory. [230] [231] [232] [233] In some tissues, RNA degradation increases with longer PMIs. 177, 230 Prolonged agonal factors, such as coma and hypoxia, together with a pH ≤5.9, can also affect the RNA integrity and have a major impact on gene expression. 232 RNA quality is reduced in a timedependent manner at a relative humidity ≥31% 231 and with freeze/ thaw cycles. 233 RNA quality control is imperative when gene expression analysis is performed by using postmortem tissues, with quantitative data checked for the influence of antemortem and postmortem parameters. 230 The RIN values are used to identify samples that should be excluded from analyses and to distinguish similar biological replicates. 230 RNA preservation may be useful in RNA expression studies of individual subjects due to possible divergence of RIN and PMI values, as well as regional tissue differences in RIN. 210 Housekeeping genes must be carefully chosen and monitored to obtain normalization.
Importantly, RIN values should serve only as a guide to determine if the tissue appears of sufficient quality to commence actual studies of gene expression. In addition to the RIN, RNA integrity has been previously tested by using northern blot hybridization, [272] [273] [274] [275] quantitative in situ hybridization, [274] [275] [276] and quantitative reverse transcription PCR. 273 For microarrays, several RNA integrity indicators, as well as the percent present call (percentage of the total number of probe sets detected as present on the array), have been used. 232 
Protein Integrity
Tryptophan, an essential amino acid in protein biosynthesis and a biochemical precursor for the biogenic amines, increases with longer PMI and is considered a good indicator of tissue quality. 55 Elevated tryptophan levels indicate protein degradation and alterations in enzyme activity. Tissue tryptophan levels also reflect freezing/packaging methods, in which lower levels are associated with dry ice storage temperatures and aluminum packing methods. 55 Although the reason for selective preservation is unknown, protein integrity may vary depending on the specific protein, cellular localization, protein posttranslational modification stage, and protein function. 210 
Tissue pH
Tissue pH values ≥6.4 are associated with higher quality samples. 178, 233, 236, 277 The pH of the tissue can be directly correlated with 8 Iodine uptake method Plasmalogens, plasmenyethanolamine, and plasmenylcholine detection 224 DIGE, polyacrylamide gel electrophoresis; ELISA, enzyme-linked immunosorbent assay; HPLC, high-pressure liquid chromatography; ICPMS, inductively coupled plasma mass spectrometry; IHC, immunohistochemistry.
agonal states (prolonged versus brief death) and with differential gene expression patterns. A prolonged terminal phase is associated with a significantly lower brain pH compared with that of rapid death. 178 Subjects with pH ≤5.9 exhibit specific changes in gene expression. 236 Tissue pH does not correlate with PMI, time in storage, freezing method, or tissue packing, but it can be influenced by gender. 178 Brain tissue pH has been shown to be remarkably consistent across different anatomic regions. 178, 233, 235 In animals, there is a rapid drop of brain tissue pH within 10 minutes after death, 261 followed by a period of pH stability for 24 to 36 hours. 235 Because pH is not a reliable indicator of storage delays and temperature fluctuations that directly affect tissue quality, pH is a better indicator of premortem events than postmortem events.
NUCLEOTIDE ISOLATION
Fresh or frozen tissues are an ideal source for DNA and RNA ( 256 • Variable correlations between mRNA and age at death 256, 257 • Gender and age affect gene expression in psychiatric disorders 232, 258 • Decreased levels of the GTP-binding proteins Gαq and Gαo were signifi cantly correlated with increased age (2%-4% loss per decade) 251 • Tryptophan levels are variable with age or gender 55, 259, 260 • Glutamate decarboxylase activity is higher in male subjects 55 
LIPID ISOLATION
Lipids can be isolated from fresh or frozen tissue (Table 7) by sample homogenization in an organic solvent at 4°C followed by an extraction protocol. 288, 294 Extracts can be stored frozen at -80°C until analysis. 287 Different lipid subtypes can be successfully quantified by using mass spectrometric detection coupled with either gas, liquid, or thinlayer chromatography. 108, 222, 223, 295 Tandem mass spectrometry with a lipid database 296 can be used to discriminate among chemical lipid variants with identical masses due to the identical number of acylic carbons and double bonds. 287 Matrix-assisted laser desorption/ ionization mass spectrometry permits the direct scanning of tissue slides, and it thus identifies the precise localization of different lipids in the tissue. 297
STORAGE PROCEDURES
Tissue samples can be cryopreserved, in either a -80°C freezer or in liquid nitrogen (-170°C), or fixed in formalin and embedded in paraffin (Tables 6 and 7) . Choosing the optimal storage protocol depends on the study end point. Embedding in paraffin is a relatively inexpensive technique with histologic morphology of high quality, but genetic material may be damaged. 18 Cryopreservation is ideal for extraction of high-quality DNA, RNA, and protein, and it is a good storage method for morphologic studies, but it is expensive. 18 Specimens should be quick-frozen either in a dry ice/isobutane mix, between chilled aluminum plates or in liquid nitrogen vapor to avoid ice crystal formation. The samples should be on a flat surface to avoid distortion. Frozen specimens are best stored in heat-sealed plastic. It is desirable to use bar coding to identify the case number and tissue sample, and tissue from multiple donors with a specific disorder should be stored in different freezers if >1 freezer is available. Freezers should be equipped with an alarm system to avoid catastrophic failure and nucleotide degradation. The inner-chamber temperature 231 ACI, the average correlation index; ASR, agonal stress rating; GTP, guanosine triphosphate; IHC, immunohistochemistry; LCM, laser microdissection; MAP, microtubule-associated proteins; mRNA, messenger RNA; RT, room temperature. by guest on October 23, 2017 http://pediatrics.aappublications.org/ Downloaded from of the freezer should be monitored at least weekly and recorded in a log. 18 The benefits of the freezer are the ability to store many samples in a relatively small storage space, with ease of access, and fewer infrastructure requirements. The disadvantages of freezers include high cost, fragility of the equipment, and the dependence on energy. 18 Liquid nitrogen storage provides better preservation of samples, independent of energy, but requires constant maintenance of the nitrogen level and is associated with a greater difficultly of accessing the samples. 18 
TISSUE DISTRIBUTION
A trained pathologist or technician may be necessary to identify and section tissue. For some specific conditions/diseases and tissues/ organs, a systemic evaluation of the tissue by a pathologist might be necessary to confirm diagnosis before distribution for research. Efforts need to be taken to prevent thawing of the tissue during the sampling procedure. Different approaches will be necessary to section the frozen tissue, including chipping, sawing, or use of a dental drill to excise tissues from large sections (ie, coronal brain section). The sample should be heat-sealed under vacuum in plastic and immediately placed in a -80°C freezer until it is packaged for shipping. Tissues are packed in inner and outer pouches consisting of an amber translucent Teflon-Kapton (Dupont, Circleville, OH)material and then heat-sealed after packaging. The pack is vacuum-sealed within a plastic bag and placed in a disposable transport box containing dry ice. 298 Commercial companies now offer a large variety of containers for temperature-sensitive shipments. 299 β-ray sterilized plastic bags and vacuum sealing of fresh excised specimens at surgical theaters, followed by time-controlled • RNA should be extracted from fresh or snap frozen material at -70°C or below 225, 226 • DNA can be obtained from sections stained with hematoxylin and eosin, 225 but toluidine blue is preferred if microdissection is required 225 • RNA can be extracted from fi xed embedded tissue, but it has usually suffered more from the treatment of the specimen before fi xation than from the processing itself 225 • When DNA is isolated by LCM from frozen solid tissue, relative humidity in the laboratory must be controlled 231 • When LCM is used, and to avoid RNA degradation, it is imperative to keep tissue sections as dry as possible after fi xation 231 Tissue fi xation and preservation
• If fi xation is needed, 4% buffered formalin is less DNA damaging than the 10% nonbuffered formalin. 229 The shorter the time a tissue is stored in buffered formalin fi xation, the better the DNA preservation 229 • Immediate immersion of tissue sample in TRIzol reagent is currently used in many laboratories to improve RNA preservation 210 • Periodical renewal of the buffered fi xative solution reduces the deleterious effects of old formalin 210 • Hepes-Glutamic Acid Buffer-Mediated Organic Solvent Protection Effect fi xation can be also successfully used 283 
Storage
• DNA can be successfully preserved for several years if stored at -80°C or below, 24,184,210 whereas some suggest that DNA is stable at 4°C for at least 3 y 284
• RNA can be successfully preserved if stored at -80°C or below 24, 184 • For optimal preservation, formalin-fi xed, paraffi n-embedded tissue should be stored as a block. Paraffi n blocks should be stored at temperatures below 27°C in an area with pest and humidity control 24
• For optimal preservation, formalin-fi xed, paraffi n-embedded tissue should be stored as a block. Paraffi n blocks should be stored at temperatures below 27°C in an area with pest and humidity controls 24 Freeze/thaw steps
• Unnecessary thawing and refreezing of frozen biospecimens or frozen samples of biomolecules extracted from the biospecimens should be avoided 24
• RNA integrity is severely affected by freeze/ thaw steps 24, 233 Detection technique
• PCR is commonly used to detect genomic or viral DNA from fresh tissue, or from LCM, formalin-fi xed, and paraffi nembedded postmortem tissues 67, 282, 285, 286 • RNA quality can be detected with high reproducibility and sensitivity with the microfl uidic chip-based capillary electrophoresis 270 304 Generic insulated shipping containers with appropriate grams of wet ice for the given time interval are used for cornea shipping (≤8°C). 305 After death, RNA integrity is influenced by the PMI, which is enhanced by higher storage temperatures. 268 The levels of proteins and posttranslational modifications are also dramatically affected at higher temperatures such as 4°C to 21°C. 234 Preservation of protein samples at 21°C for >12 hours decreases biochemical reliability. In addition, thawed tissue stored at 21°C and then refrozen is no longer usable for biochemical studies. 234 
TRANSMISSION OF GENETIC TESTING RESULTS TO FAMILIES
Thresholds have been established for reporting genetic testing results to study participants, with 3 key criteria: (1) the risk for the disease should be significant (variants with greater penetrance or associated with younger age of onset should receive priority); (2) the disease should have important health implications (ie, fatal or substantial morbidity); and (3) proven therapeutic or preventive interventions should be available. In addition, the genetic results should come only from certified laboratories. 307,308
CONCLUSIONS
This review summarizes pertinent issues regarding the procurement and storage of solid tissues from children. Due to the variability in collection method, site, time, and storage conditions of tissues, it is imperative to understand the factors affecting tissue quality. Standardization of methods of collection and linked clinical information will aid reliable research results. Minimal quality control measures for solid tissue are required for each study, 184 which may include a search of donor information, record of agonal states, standardization of PMIs, standardization of sample collection and storage processes, histologic reviews of samples to assess proper biospecimen identification, and the use of best practices for molecule isolation. Translational research on solid tissues will contribute to new diagnostics and therapeutics in child diseases.
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TABLE 7 Sample Processing and Storage Tips for Protein and Lipids
Parameter
Proteins Lipids
Source of material
• Proteins should be extracted from fresh or snap frozen material at -70°C or below 184, 210, 234 • Lipids should be extracted from fresh or snap frozen material at -20°C 108 or -80°C 223, 287 Time to freeze • Freeze immediately after isolation. Samples derived postmortem should be frozen (at -80°C) short after death (maximum 2 h) for optimal results in protein studies and to avoid protein degradation 210, 234 • Freeze immediately after isolation. Samples derived postmortem should be frozen (at -20°C to -80°C) shortly after death (maximum 6-8 h) for optimal results in lipids studies 108 Extraction protocol
• General buffer for protein extraction and/or homogenization can be used with fresh or frozen samples 233, 234, 265, 267 • e Including the presence of alcohol or drugs in the body at time of death, macroscopic changes in the organs at time of autopsy, and evidence of hypoxia/ischemia. Blood test results from autopsy are also included in these details. f Especially for studies involving several generations within the same family. g NA for fresh resection after neurologic death or cardiac death. h Updated regularly. i RIN, tissue pH, and/or protein assay. j Record of thaw/freeze cycles before it is used for research. k During dissection some tissues cannot be separated properly from others and must be specifi ed before research is conducted. l The time during which a tissue/organ remains at physiologic temperature during decreased blood perfusion or in the absence of blood supply. m The time during which a tissue/organ remains cold during decreased blood perfusion or in the absence of blood supply. Also the time between tissue removal and cell/tissue preparation; 1 example is islet preparation from the pancreas. n Specifi c for research studies of eye tissue.
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